Hyperuricemia
Mostrando 13-24 de 59 artigos, teses e dissertações.
-
13. Are patients with lichen planus really prone to urolithiasis? Lichen planus and urolithiasis
ABSTRACT Purpose to investigate whether patients with lichen planus (LP) are really prone to urolithiasis or not. Patients and Methods We performed a prospective analysis of 40 patients diagnosed with lichen planus (LP) (group I), and 40 volunteers did not have LP before (group II). Participants were all checked for urolithiasis by radiological investiga
Int. braz j urol.. Publicado em: 2016-06
-
14. What is the Incidence of Kidney Stones after Chemotherapy in Patients with Lymphoproliferative or Myeloproliferative Disorders?
Introduction This study describes the incidence and risk factors of de novo nephrolithiasis among patients with lymphoproliferative or myeloproliferative diseases who have undergone chemotherapy. Materials and Methods From 2001 to 2011, patients with lymphoproliferative or myeloproliferative disorders treated with chemotherapy were retrospectively ident
Int. braz j urol.. Publicado em: 2014-12
-
15. Serum uric acid and disorders of glucose metabolism: the role of glycosuria
Hyperuricemia has been associated with hypertension, diabetes mellitus, and metabolic syndrome. We studied the association between hyperuricemia and glycemic status in a nonrandomized sample of primary care patients. This was a cross-sectional study of adults ≥20 years old who were members of a community-based health care program. Hyperuricemia was defined
Braz J Med Biol Res. Publicado em: 22/08/2014
-
16. Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention
Clinics. Publicado em: 2013-07
-
17. The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine
OBJECTIVES: Hyperuricemia is a risk factor for contrast-induced acute kidney injury in patients with chronic kidney disease. This study evaluated the value of hyperuricemia for predicting the risk of contrast-induced acute kidney injury in patients with relatively normal serum creatinine who were undergoing percutaneous coronary interventions. METHODS AND RE
Clinics. Publicado em: 2013-01
-
18. Alopurinol na prevenção da esteato-hepatite não alcoólica e hiperglicemia induzida por dieta rica em frutose em ratos wistar
Nonalcoholic fatty liver disease (NAFLD) in the last two decades has been recognized as the most common chronic liver disease in Western countries, paralleling the epidemic of obesity and consumption of high-fructose diet. Researchers suggest that NAFLD may be the hepatic manifestation of metabolic syndrome. Although NAFLD and hyperuricemia are strongly rela
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 27/03/2012
-
19. Nefropatia crônica por ciclosporina : papel do ácido úrico e do sistema renina angiotensina aldosterona como mediadores de disfunção endotelial, inflamação e vasculopatia / Cyclosporine nephropathy : effect of uric acid and the renin angiotensin aldosterone system as mediators of endothelial dysfunction, inflammation vasculopathy
Chronic allograft nephropathy is characterized by stripped tubular atrophy and interstitial fibrosis, in presence of arteriolar hyalinosis, resembling an ischemic pattern of chronic kidney disease. Chronic ischemia is associated with reduced glomerular filtration rate, and increase in serum uric acid levels. Cyclosporine per se also has a direct effect on tu
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 03/08/2011
-
20. Noncrystalline uric acid inhibits proteoglycan and glycosaminoglycan synthesis in distal tubular epithelial cells (MDCK)
Hyperuricemia is associated with renal stones, not only consisting of uric acid (UrAc) but also of calcium oxalate (CaOx). Glycosaminoglycans (GAGs) are well-known inhibitors of growth and aggregation of CaOx crystals. We analyzed the effect of noncrystalline UrAc on GAG synthesis in tubular distal cells. MDCK (Madin-Darby canine kidney) cells were exposed t
Brazilian Journal of Medical and Biological Research. Publicado em: 2010-10
-
21. Prevalence of hyperuricemia and associated nutritional factors: a cross-sectional study nipo-Brazilian city of Bauru / Prevalência de hiperuricemia e fatores nutricionais associados: um estudo transversal com nipo-brasileiros do município de Bauru
O objetivo do presente trabalho foi estimar a prevalência de hiperuricemia em nipo-brasileiros do município de Bauru (São Paulo), bem como verificar a existência de associações dessa doença com fatores nutricionais. MÉTODOS: Foram obtidos dados de 1.330 indivíduos por meio de questionários previamente testados (dados demográficos, histórico de sa
Publicado em: 2009
-
22. Componentes da síndrome metabólica em portadores de obesidade mórbida, segundo diferentes níveis de uricemia. / Metabolic syndrome in patients with morbid obesity, according to different levels of serum uric acid.
Although uric acid has a character antioxidant, when in increased serum levels, has been associated in several studies with various pathological conditions, particularly with obesity, cardiovascular disease, diabetes mellitus, dyslipidemia, hyperinsulinemia and insulin resistance, this being identified as the primary change of the metabolic syndrome. However
Publicado em: 2009
-
23. Efeito da utilização de agentes hipouricemiantes sobre a pressão arterial de animais espontaneamente hipertensos / Uric acid lowering agents reduces blood pressure in spontaneous hypertensive rats
Hyperuricemia is associated with vascular remodeling and hypertension in experimental models, and use of uric acid (UA) lowering agents is associated with BP normalization and protection of renal disease. Aim: To determine the effect of UA lowering agents on BP in SHR animals. Methods: Male SHR and WKY rats, 4 weeks old, were followed for 9 weeks. SHR animal
Publicado em: 2009
-
24. Fatores prÃ-aterotrombÃticos associados à SÃndrome MetabÃlica X na populaÃÃo de Pernambuco â Nordeste â Brasil
Metabolic Syndrome X (MSX) is a cluster of at least three metabolic disorders, among which insulin resistance/compensatory hyperinsulinemia, hyperglycemia, obesity and/or abdominal obesity, hypertension, characteristic dyslipidemia with hypertriglyceridemia and/or reduction of levels of cholesterol in high-density lipoprotein (HDL-c), and other pro-atherothr
Publicado em: 2009